08-02-2024 |
AH |
|
APDN |
Applied DNA Sciences, Inc. |
7.74 |
-0.09 |
-0.31 |
-0.14 |
Applied DNA Sciences GAAP EPS of -$0.09 beats by $0.22, revenue of $0.89M beats by $0.11M [2/8/2024 5:13 PM] |
0.5950 |
0.0 (-0.83%) |
0.62 |
0.02 (3.33%) |
0.52 - 1.86 |
120,155 |
60,000 |
613 |
|
|
07-12-2023 |
AH |
|
APDN |
Applied DNA Sciences |
14.00 |
-0.26 |
-0.27 |
0.00 |
Applied DNA Sciences GAAP EPS of -$0.26 beats by $0.01, revenue of $0.78M misses by $0.9M [12/7/2023 5:51 PM] |
0.8811 |
-0.20 (-18.42%) |
1.08 |
0.0 (0.00%) |
0.75 - 1.92 |
144,164 |
40,000 |
203 |
|
|
10-08-2023 |
AH |
|
APDN |
Applied DNA Sciences, Inc. |
20.01 |
-0.24 |
-0.24 |
-0.33 |
Applied DNA Sciences GAAP EPS of -$0.24 in-line, revenue of $2.92M beats by $0.36M [8/10/2023 5:21 PM] |
1.54 |
-0.21 (-11.71%) |
1.74 |
-0.01 (-0.57%) |
0.97 - 4.90 |
86,345 |
120,000 |
624 |
|
|
11-05-2023 |
AH |
4:10 PM ET (May 11) |
APDN |
Applied DNA Sciences, Inc. |
13.94 |
-0.20 |
-0.17 |
-0.28 |
Applied DNA Sciences GAAP EPS of $0.05 beats by $0.25, revenue of $4.41M beats by $0.28M [5/11/2023 4:13 PM] |
1.09 |
0.01 (0.93%) |
1.11 |
0.03 (2.78%) |
0.62 - 7.35 |
62,621 |
70,000 |
36,067 |
|
|
09-02-2023 |
AH |
4:10 PM ET (Feb 9) |
APDN |
Applied DNA Sciences, Inc. |
21.94 |
-0.14 |
-0.33 |
-0.63 |
Applied DNA Sciences GAAP EPS of -$0.30 misses by $0.01, revenue of $5.26M beats by $1.09M [2/9/2023 4:15 PM] |
1.65 |
0.0 (0.00%) |
1.65 |
0.0 (0.00%) |
0.62 - 7.35 |
206,548 |
150,000 |
1,623 |
|
|
14-12-2022 |
AH |
4:10 PM ET (Dec 12) |
APDN |
Applied DNA Sciences, Inc. |
19.07 |
N/A |
-0.26 |
-0.49 |
Applied DNA Sciences GAAP EPS of -$0.93 beats by $0.26, revenue of $18.17M misses by $0.54M [12/14/2022 4:37 PM] |
1.40 |
0.0 (0.00%) |
1.36 |
-0.04 (-2.86%) |
0.62 - 7.35 |
98,420 |
130,000 |
5,072 |
|
|
12-05-2022 |
AH |
4:05 PM ET (May 12) |
APDN |
Applied DNA Sciences, Inc. |
10.62 |
-0.28 |
-0.30 |
-0.33 |
Applied DNA Sciences GAAP EPS of -$0.23 beats by $0.10, revenue of $6.15M beats by $1.65M [5/12/2022 4:09 PM] |
1.38 |
0.14 (11.30%) |
1.41 |
0.17 (13.71%) |
1.08 - 8.10 |
12,197 |
40,000 |
217 |
|
|
10-02-2022 |
AH |
4:05 PM ET (Feb 10) |
APDN |
Applied DNA Sciences, Inc. |
25.15 |
-0.63 |
-0.19 |
-0.62 |
Applied DNA Sciences GAAP EPS of -$0.63, revenue of $4.17M [2/10/2022 4:35 PM] |
2.61 |
-0.50 (-16.08%) |
2.85 |
-0.26 (-8.36%) |
2.55 - 13.64 |
322,093 |
70,000 |
11,568 |
|
|
09-12-2021 |
AH |
4:05 PM ET (Dec 9) |
APDN |
Applied DNA Sciences, Inc. |
38.70 |
-0.49 |
-0.31 |
-0.82 |
Applied DNA Sciences EPS misses by $0.23, beats on revenue [12/9/2021 4:07 PM] |
4.91 |
-0.17 (-3.39%) |
5.13 |
0.05 (0.98%) |
4.65 - 13.64 |
744,444 |
1,350,000 |
265,050 |
|
|
12-08-2021 |
AH |
4:10 PM ET (Aug 12) |
APDN |
Applied DNA Sciences, Inc. |
47.54 |
-0.46 |
-0.23 |
-0.72 |
Applied DNA Sciences EPS misses by $0.20, misses on revenue [8/12/2021 4:55 PM] |
6.00 |
-0.20 (-3.23%) |
6.22 |
0.02 (0.32%) |
4.95 - 13.64 |
1,144,608 |
3,030,000 |
7,744 |
|
|
13-05-2021 |
AH |
4:05 PM ET (May 13) |
APDN |
Applied DNA Sciences, Inc. |
49.85 |
-0.33 |
-0.18 |
-0.79 |
Applied DNA Sciences EPS in-line, beats on revenue [5/13/2021 4:25 PM] |
6.15 |
0.22 (3.78%) |
6.02 |
0.09 (1.52%) |
4.95 - 16.39 |
305,989 |
1,690,000 |
4,870 |
|
|
11-02-2021 |
AH |
4:05 PM ET (Feb 11) |
APDN |
Applied DNA Sciences, Inc. |
81.21 |
-0.62 |
-0.55 |
-1.12 |
Applied DNA Sciences EPS misses by $0.34, beats on revenue [2/11/2021 4:17 PM] |
11.75 |
-0.82 (-6.52%) |
10.65 |
-1.92 (-15.27%) |
2.52 - 16.39 |
1,253,644 |
1,459,545 |
161,051 |
|
|
17-12-2020 |
AH |
4:05 PM ET (Dec 17) |
APDN |
Applied DNA Sciences, Inc. |
31.89 |
-0.82 |
-0.59 |
-1.44 |
Applied DNA Sciences EPS misses by $0.30, misses on revenue [12/17/2020 4:19 PM] |
5.20 |
-1.04 (-16.75%) |
5.26 |
-0.98 (-15.71%) |
2.52 - 16.39 |
840,548 |
586,762 |
73,943 |
|
|
06-08-2020 |
AH |
4:05 PM ET (Aug 6) |
APDN |
Applied DNA Sciences, Inc. |
45.33 |
-0.72 |
-0.62 |
-1.60 |
Applied DNA Sciences EPS misses by $0.04, misses on revenue [8/6/2020 4:10 PM] |
9.87 |
-1.10 (-10.03%) |
9.93 |
-1.04 (-9.48%) |
2.52 - 19.69 |
472,613 |
2,429,807 |
18,930 |
|
|